Detalhe da pesquisa
1.
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation.
J Infect Dis
; 229(1): 83-94, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440459
2.
Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases.
J Autoimmun
; 136: 103024, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001437
3.
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling.
Haematologica
; 108(4): 1105-1114, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770529
4.
Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Clin Infect Dis
; 75(1): 88-97, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596213
5.
Current attitude to deferral of cellular therapy or nontransplant chemotherapy due to SARS-CoV-2 asymptomatic infection: Survey of Infectious Diseases Working Party EBMT.
Transpl Infect Dis
; 24(2): e13773, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918856
6.
Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
J Infect Dis
; 223(9): 1564-1575, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32860509
7.
Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report.
Biol Blood Marrow Transplant
; 25(2): 335-342, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30243581
8.
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 104(9): 1782-1788, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733269
9.
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation.
Haematologica
; 104(5): 929-936, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655377
10.
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.
Ann Hematol
; 98(7): 1755-1763, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30993417
11.
Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT.
Bone Marrow Transplant
; 59(1): 59-65, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37872300
12.
Pneumocystis Pneumonia After Allogeneic Hematopoietic Cell Transplantation: A Case-Control Study on Epidemiology and Risk Factors on Behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Transplant Cell Ther
; 30(2): 235.e1-235.e10, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007092
13.
Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
J Infect
; 88(6): 106162, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38663756
14.
Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party.
EClinicalMedicine
; 67: 102393, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38152413
15.
Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey.
Bone Marrow Transplant
; 58(4): 414-423, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653669
16.
Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study.
Bone Marrow Transplant
; 58(5): 558-566, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849806
17.
Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT.
Bone Marrow Transplant
; 58(8): 881-892, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37149673
18.
Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.
Front Immunol
; 14: 1125824, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36960069
19.
HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party.
Bone Marrow Transplant
; 57(2): 167-175, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34689177
20.
Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients - Study of infectious diseases working party of EBMT.
J Infect
; 84(1): 71-79, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34757138